SP1 and colorectal cancer: In humans and rats, SP1, SMADs, and hypoxia-inducible factor-1 activate transcription via direct binding to the promoter region of NT5E [41,42,43], whereas peroxisome proliferator-activated receptor gamma (PPAR-γ) suppresses its transcription in human colorectal cancer [44].